MIS
Lambeth, United Kingdom
MIS
Lambeth, United Kingdom

Time filter

Source Type

DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "US Market Report for MIS Interbody Devices 2017 - MedCore" report to their offering. Traditionally, these devices were implanted through open surgery. However, a growing number of these devices are being implanted using minimally invasive surgery (MIS) techniques. MIS spinal fusion is made possible by complex and innovative surgical technology, allowing implantation of posterior screw/rod and interbody devices with minimal surgical damage or harm to the patient. Proponents of MIS report that patients experience less trauma, have shorter hospital stays, use less medication after surgery and return to work sooner than patients who undergo open surgery. Skeptics of these techniques question the quality of the operation and cite that reduced access to the spine may compromise their ability to address the pathology. Interbody devices, which are sometimes referred to as interbody cages, vary widely, and there are multiple ways of classifying them. In terms of design, interbody devices come as cages or spacers, each varying in size and shape. For the purpose of this report, interbody devices are segmented by surgical approach. For more information about this report visit http://www.researchandmarkets.com/research/vbh9gf/us_market_report


DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "US Procedure Numbers for Minimally Invasive Spinal Implants 2017 - MedPro" report to their offering. The spinal implant market is considered by many to be the most exciting and controversial segment of the orthopedics industry. This market has traditionally been a segment of the orthopedics market, but due to rapid growth and a large market size, many manufacturers view spine as a key business division separate from traditional orthopedics. Rapid growth is expected in all segments of the U.S. minimally invasive spinal implant market as a result of the physiological and surgical advantages of MIS procedures over open procedures. One of the key drivers for the MIS spinal device market is the increase in the target population, which is composed of aging baby boomers. The majority of procedures are performed on those individuals in the final third and quarter of their lifespan, usually over the age of 60. This age group is the fastest growing demographic cohort in the United States. The biggest limiting factor for the MIS spinal device market is the complexity of the procedures and the skill required to master them. In particular, percutaneous techniques, and, to a lesser extent, retractor techniques, are considered by many to be considerably more difficult to master than traditional open surgical methods. Older generations of doctors and surgeons are especially reluctant to switch to MIS, as it takes a considerable time investment to master the procedure. The MIS interbody market continues to see a shift toward OLIF and LLIF devices and away from MIPLIF and MITLIF devices. The oblique and lateral lumbar approaches are expected to see more growth than their posterior and transforaminal lumbar counterparts, although positive growth is expected across segments. For more information about this report visit http://www.researchandmarkets.com/research/5jlzf5/us_procedure


News Article | May 19, 2017
Site: marketersmedia.com

— Dalum Software LLC recently announced the launch of a cloud version of their Membership Integrity System (MIS) gym software. In the past, the tool was available as a desktop integrated software program for gyms and fitness facilities. Today, it is available on the cloud, providing even greater access and flexibility for clients. “With the cloud, our customers now have access to our innovative software solutions regardless of where they are,” stated company representative Gerald Dalum. “MIS doesn’t force a certain device or operating system. Regardless of if your gym facility has a mac, pc, phone or tablet, you can still access our system as long as the device has a modern browser and internet connectivity.” With the new cloud-based software offered by https://www.mis.io, clients no longer have to worry about backing up data or paying to have the software reinstalled. Additionally, gym and membership facility owners can access the software from any location, which allows them to keep tabs on what is going on even when they are on vacation or at home. “The cloud version of our mis.io software is compatible with a wide array of membership based industries,” continued Dalum. “For example, if you have a dance studio and basic gym together, our mis.io software can manage both types of businesses with the same software at the same time. No longer do you have to utilize two different types of software. Also, now that it is available on the cloud, access is more available than ever before.” The adoption of the cloud across all industries is growing significantly. Each year, more and more business owners are seeing the value offered by this technology. With the new cloud-based services by www.mis.io fitness facilities and gyms now have access to the software they need for mission critical applications without being tethered to hardware that doesn’t provide access while away from the office. Founded in 2005, Dalum Software, LLC was created to provide better and innovative gym membership software solutions. The owner of the company created a user-friendly design that quickly gained popularity in the local area. Today, MIS is a worldwide brand that is used by membership facilities to manage all aspects of the business. The mission of the company in the beginning and still today was to create affordable and easy to use software solutions that can be utilized by anyone, not just computer experts. For more information, please visit https://www.mis.io


LOS ANGELES--(BUSINESS WIRE)--Westlake Financial Services recently contracted Bill Jensen to focus on developing its Strategic Accounts division. In this role, he will analyze all aspects of strategic account relationships to maximize business for dealerships and Westlake. “Westlake’s relationships with strategic accounts are crucial to continued growth primarily because these accounts consist of the largest and most growth orientated dealer groups in the U.S.,” commented Jensen. “Westlake Financial is a strong competitor in the industry, successfully serving both franchise and independent dealers nationwide through its integration of technology and constant innovation. Westlake’s full range of financial services products and full-spectrum lending capabilities are a solid fit for auto dealers of all sizes.” Jensen looks to leverage his extensive background in indirect auto lending from JP Morgan Chase, Mazda and Bank of America to provide Westlake measurable strategies to expand in this segment. Jensen began his career in auto finance with Bank of America in 1972 joining their management trainee program. In 1973, he joined Security Pacific Bank as an indirect auto collector, worked in various roles in both credit and sales and was appointed Head of Business Development in 1989. In 1993, Jensen became Manager of Dealer Financial Services at Mazda Motor of America where he expanded Mazda's captive finance relationship with Primus, a subsidiary of Ford Motor Credit. Jensen returned to Bank of America in 1995 in the role of National Sales and Marketing Manager in which he helped design and launch its national indirect lending platform. He joined Bank One in 1999 as Director of Marketing; in 2005, the company was acquired by JP Morgan Chase and Jensen was appointed Custom Finance Senior Executive, a position in which he was responsible for sub-prime business and processes including originations, booking and funding, collections, pricing and profitability, dealer management, dealer administration, MIS and sales. In 2012, he became National Retail Lending Credit Executive and was responsible for Chase Auto Finance Credit originations, booking and funding provided to over 17,000 auto dealerships nationwide. In 2014, Jensen was appointed Senior Credit Executive and was responsible for major credit origination process and control improvement projects until his retirement in 2016. “Bill brings over 45 years of experience to this role,” commented Ian Anderson, Group President – Westlake Financial Services. “His knowledge will provide us even deeper insight into the needs and interests of these unique groups. We are dedicated to solidifying our position as the selected indirect lender for strategic accounts nationwide and we are confident that Bill will heavily contribute to this initiative.” About Westlake Financial Services: Westlake is an internet based, privately held finance company that specializes in the acquisition and servicing of prime to sub-prime automotive retail installment contracts. Headquartered in Southern California, Westlake originates indirect retail installment contracts through a network of over 30,000 new and used car dealers throughout the United States.


News Article | May 29, 2017
Site: www.businesswire.com

DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "US Market Report for Facet Fixation 2017 - MedCore" report to their offering. Percutaneous minimally invasive surgery (MIS) is the least invasive of all MIS procedures. These procedures are performed using small needle-like, tubular instrumentation. The tubes act as a pathway for the insertion of screws or rods. All percutaneous systems use cannulated screws, which have a central cavity by which they are fed along a guidewire in the tube, allowing accurate implantation without directly viewing the surgical site. Facet fixation is one type of percutaneous minimally invasive surgery in which the facet joints in the thoracolumbar region are fused using facet screws, bolts or allograft dowels. Facet screw fixation offers the advantage of placing a single screw across each articulating facet joint to immobilize a motion segment, thereby reducing the amount of hardware (and therefore exposure) necessary for fusion. As representative of another emerging technology in the minimally invasive field, the facet fixation market will experience growth trends similar to the spinous process fixation market. The market has experienced high initial growth over the last five years, which has been attributed to increasing awareness of the procedure, as well the entrance of new competitors, and new products, into the market. Growth in this market is driven by the advantages that minimally invasive facet fixation surgeries have over traditional (open) pedicle screw procedures. These benefits include decreased blood loss, fewer disruptions to neighboring tissues and structures, and reduced recovery and intraoperative times. Overall, facet fixation technologies are cannibalizing cases that previously would have been treated with pedicle screws, such as grade I and II spondylolisthesis. For more information about this report visit http://www.researchandmarkets.com/research/2vdhpd/us_market_report


NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER UNITED STATES WIRE SERVICES Aurora Spine Corporation ("Aurora Spine" or the "Company") (TSX VENTURE:ASG) announces financial results for the three months ended March 31, 2017. Q1 2017 saw sales consistent with Q1 2016. During the three months ended March 31, 2017 we generated revenues in the amount of $1,526,377 compared to $1,549,125 during the same period the previous year, a decrease of 1%. During Q1 2017, we continued to expand the availability of our family of products in our Screwless Procedure™, a cutting-edge surgical approach to spine fusion. The Screwless Procedure features: our patented ZIP® MIS Fusion System, our TiNano® Interbody cages, and our COMPASS 4D™ retractor system. The following table summarizes selected key financial data. The Screwless Procedure has been developed to increase the possibility of significant benefits to patients, hospitals, and surgeons, including reduced surgery time, less blood loss, shorter hospital stays, and significantly faster recovery time. These benefits will continue to be the driving force of Aurora Spine's competitive advantage and growth. In Q1 2017, we continued driving growth by training surgeons and distributors on Aurora Spine's unique technology and increasing the reach of our sales force. In 2017, we will focus on: We expect that these initiatives will create value for our shareholders. Management and I thank our shareholders for their continued support in these endeavors. We will look to extend our technology position further with minimally disruptive procedural solutions for the spine. None of this would be possible without the dedication and commitment of our hardworking colleagues at Aurora. I want to thank them for the great accomplishments they have made this year, for Aurora and ultimately, for patients. They have embraced change and risen to the numerous challenges before them, and I am grateful for their ongoing support of our company and our mission. I would also like to thank you, our investors, for your continued support. Together, we have built a strong foundation, and I look forward to the opportunities ahead of us. I am truly grateful to be part of an organization that makes such a positive improvement in the lives of patients around the world. The statements together with the Management Discussion and Analysis can be found on SEDAR at www.sedar.com. About Aurora Spine Aurora Spine is focused on bringing new solutions to the spinal implant market through a series of innovative, minimally invasive, regenerative spinal implant technologies.


News Article | May 24, 2017
Site: www.prweb.com

Medpricer, the only complete cost management solution for purchased services, together with TPC, a partnership of independent hospitals formed as a regional purchasing coalition across Arkansas, Missouri and Texas, have announced a complimentary webinar on “How TPC Uses Precision Benchmarking to Supercharge Negotiation Success and Savings.” The webinar will take place at 11:00 am EDT on Wednesday, May 31st. Healthcare organizations are under extreme pressure to reduce operating costs and they use benchmarks to help them determine how much cost reduction is possible. However, using the same approach for purchased services as for purchased goods and capital is ineffective. “In purchased services, many organizations rely on simple ratios comparing purchased services spend to number of beds, square footage, etc. While this may work as a rough cut to judge relative orders of magnitude, it’s not generally effective data for a successful supplier negotiation. But with Medpricer precision benchmarking you have the exact data you need,” said Medpricer CEO Chris Gormley. “Medpricer precision benchmarking leverages contract details and Medpricer’s competitive bidding results to create a detailed assessment of what price and terms you should be paying so that you can provide suppliers with data-backed expectations,” he explained. In this impactful webinar participants will learn: “TPC has proven itself as a frontrunner in purchased services contracting. Through our dedicated focus, we have demonstrated industry-leading results for our Members year after year. By partnering with Medpricer, we have had the opportunity to enhance our purchased services strategy and thus increase the value we can provide to our Members,” says TK Khen, Director of Purchased Services at TPC. “At this event, participants will gain insights into how we leveraged Medpricer’s nationwide data to confidently challenge existing suppliers on their pricing, service levels and terms resulting in increased savings and a more efficient process to advance negotiations faster,” he added. For more information and to register for the webinar, visit http://info.medpricer.com/precision-benchmarking-tpc. About the presenters: TK Khen, TPC Director of Purchased Services, collaborates with the TPC Purchased Services team and TPC Members to identify, evaluate and execute savings opportunities. TK holds an MBA in MIS and Marketing, and a BS in Business Administration from the University of Texas at Dallas and is certified as a Master Project Manager. Chris Gormley, CEO of Medpricer, sets the strategic direction for continuous innovation, improvement, and growth at Medpricer, drawing from a wealth of experience in Cloud Technology, electronic Sourcing, and Healthcare. Chris earned an MBA in Finance & Strategy from the Wharton School and a BS degree with high distinction in Chemical Engineering from Worcester Polytechnic Institute. About Medpricer Medpricer provides a complete Purchased Services cost management platform that improves operating margins through superior visibility, savings, and control over unmanaged spending. Medpricer empowers healthcare providers with technology so that they can independently find, get, and keep purchased services savings. For more information, please visit http://www.medpricer.com/. About TPC Based in Plano, Texas, TPC is a partnership of community-based hospitals that work together as a single system to aggregate business volume and leverage economies of scale without sacrificing individual independence or local ownership. By working through a committed platform, TPC drives collaboration and innovation across a range of clinical, operational and economic areas enabling providers to maximize the financial and non-financial value they receive. TPC represents 11 health systems and approximately $1 billion in purchasing volume, and has achieved $180 million in savings since 2010. TPC exists for the sole purpose of helping healthcare organizations remain strong and independent. For more information, visit http://www.tpc1.com.


JACKSONVILLE, Fla.--(BUSINESS WIRE)--NovaBone Products, a leading biologics medical device company, announces the addition of NovaBone IRM and NovaBone IRM MacroPOR to its portfolio of biologically active bone graft substitutes. NovaBone IRM, and NovaBone IRM MacroPOR are the most advanced bioactive synthetic bone graft substitutes available to the orthopedic community today. Both formulations optimize osteogenesis, uniquely signal and stimulate osteoblastic activity, and offer angiogenic potential. By design, both formulations are highly irrigation resistant with excellent cohesion and handling properties. “NovaBone Products’ base Bioactive Glass technology has proven to out-perform traditional calcium sulfate based synthetic products and demineralized bone matrix products,” said Dennis McBride, Vice President of Sales and Marketing. “We are now advancing our science further by providing formulations with carriers that have a synergistic effect in bone formation and retain molded shapes following implantation and irrigation.” Novabone offers the broadest portfolio of bioactive synthetic bone graft substitutes in the world, with a robust pipeline of products in development designed to expand the regenerative biologics products the company offers. Presently, products offered include minimally invasive (MIS) delivery devices, strip formulations, putty materials that are hydrated using bone marrow aspirate, and putty formulations that are ready-to-use out of the package. “We are proud to offer products that allow a surgeon to look to one company when addressing bone grafting needs,” concluded McBride. NovaBone Products, a privately held company based in Florida, USA since 2002 and a recognized industry leader in bioactive glass design and manufacturing, developed the first bioactive synthetic bone graft offered to the orthopaedic community.


Despite increasing unit sales, increased competitiveness within the total patient monitoring market has had a negative impact on market growth. The entry of low cost foreign competition has been especially disruptive. However, the long-term prospects remain positive as demand for quality patient monitoring solutions will enable unit sales growth to outpace pricing pressure. Philips Healthcare is the leading competitor in the Australian patient monitoring market. The company competes in the multi-parameter vital sign monitoring market, wireless telemetry, pulse oximetry and fetal/neonatal monitoring markets. Their IntelliVue™ and SureSigns™ product lines range from low to high-acuity and have flexible product designs ranging from extremely compact to portable bedside units. GE Healthcare is the second leading competitor in the Australian patient monitoring market. GE offers an extensive product line that not only includes a range of low- to high-acuity monitoring devices, but also telemetry devices and networking solutions. Their product lines include the CARESCAPE™ B series and new B40™ patient monitors which can feed into the CARESCAPE™ central stations and mobile viewers to access patient information. Additional competitors in the Australia patient monitoring market include Dräger Medical, Medtronic, Mindray, Nihon Kohden, Natus Medical, Compumedics, Welch Allyn, Spacelabs Healthcare, Nonin and Smiths Medical among others. More on the patient monitoring device market in Australia can be found in a series of reports published by iData Research entitled the Australia Market Report Suite for Patient Monitoring Equipment. The suite covers reports on the following markets: multi-parameter vital signs monitoring, wireless ambulatory telemetry monitoring, telehealth, electromyogram monitoring, electroencephalogram monitoring, fetal and neonatal monitoring, pulse oximetry and blood pressure monitoring devices. The iData report series on patient monitoring devices covers the U.S., China, Australia, India, Japan, South Korea and 15 countries in Europe including Germany, France, the United Kingdom (U.K.), Italy, Spain, Benelux (Belgium, Netherlands and Luxemburg), Scandinavia (Finland, Denmark, Sweden and Norway), Portugal, Austria and Switzerland. Reports provide a comprehensive analysis including units sold, market value, forecasts, as well as detailed competitive market shares and analysis of major players' success strategies in each market and segment. To find out more about patient monitoring device market data, register online or email us at info@idataresearch.net for an Australia Market Report Suite for Patient Monitoring Equipment brochure and synopsis. iData Research (www.idataresearch.com) is an international market consulting research firm, dedicated to providing the best in business intelligence for the medical device industry. Our research empowers our clients by providing them with the necessary tools to achieve their goals and do it right the first time. iData covers research in: Ultrasound, X-Ray Imaging, Diagnostic Imaging, Oncology, Ophthalmics, Vascular Access, Laparoscopy, Urology, Gynecology, Endoscopy, Dental Operatory Equipment, Dental Material, Dental Lasers, Dental Prosthetics, Dental CAD/CAM, Dental Bone Graft Substitutes, Interventional Cardiology, Cardiac Surgery, Cardiac Rhythm Management, Electrophysiology, Operating Room Equipment, Surgical Microscopes, Robotics and Surgical Navigation, Spinal Implants and VCF, Spinal MIS, Orthopedic Soft Tissue Repair and Regeneration, Orthopedic Trauma, Large & Small Joints, Anesthesiology, Wound Management, Orthopedics and more. We have built a reputation and earned our clients' trust based on consistent and uniquely intelligent research that allows our customers to make confident decisions and impact their businesses. A combination of market expertise and over a decade of experience has resulted in a deep understanding of the medical device industry that has inspired innovation and propelled our clients to success. To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/philips-and-ge-healthcare-lead-the-australia-patient-monitoring-equipment-market-due-to-the-adoption-of-less-invasive-more-accessible-patient-centric-device-configurations-300464048.html


The ASP decline is reinforced by competition among discount and value companies. However, the moderate growth rate of the U.S. dental implant industry has spurred the development and acceptance of technologies that facilitate dental implant placement and restoration. In turn, these technological advancements will further drive dental implant replacement rates. Additionally, technological advancements incorporated into dental software suites are set to drive sales, especially software that falls under premium brands. However, downward price pressure and the market entry of low-cost competitors will continue to offset gains in unit sales, resulting in moderate market values. The market has been restructuring, with discounted and value brands gaining popularity in the market. Generic and imitation abutments are growing more acceptable. Instrument kits are increasingly being given away. Treatment planning software is now bundled to help retain loyal customers. Discounted surgical guides are growing more prevalent. These market limiters have largely impacted market value and revenue potential in the overall U.S. market. The dental implant fixtures and final abutments market in the U.S. is largely controlled by three main companies: Nobel Biocare, Straumann and Dentsply Sirona. In addition to their current dominance in the market, they are also very active with ongoing acquisitions to further secure their leading positions. The leading competitors have also been able to maintain their ranking through a history of brand loyalty. The dental market is dominated by specialists such as periodontists and oral surgeons, who generally prefer premium brands. As a consequence, the premium companies are expected to maintain their dominance in upcoming years. As discount and value brands continue to emerge on the market, premium leaders are expected to continually lose market share. However, the market leaders have engaged in price cutting and bundling of large-scale purchases to remain competitive. Additional competitors in the U.S. dental implant fixtures market include Zimmer Biomet, BioHorizons, Implant Direct and MIS Implants among others. More on the dental implant market in the U.S. can be found in a series of reports published by iData Research entitled the U.S. Market Report Suite for Dental Implant Fixtures and Final Abutments. The suite covers reports on the following markets: dental implant fixtures, final abutments, dental implant instrument kits, treatment planning software and surgical guides. The iData report series on dental implants covers the U.S., Argentina, Brazil, Mexico, China, Australia, Japan, South Korea and 15 countries in Europe including Germany, France, the United Kingdom (U.K.), Italy, Spain, Benelux (Belgium, Netherlands and Luxemburg), Scandinavia (Finland, Denmark, Sweden and Norway), Portugal, Austria and Switzerland. Reports provide a comprehensive analysis including units sold, market value, forecasts, as well as detailed competitive market shares and analysis of major players' success strategies in each market and segment. To find out more about dental implant market data, register online or email us at info@idataresearch.net for a U.S. Market Report Suite for Dental Implant Fixtures and Final Abutments brochure and synopsis. iData Research (www.idataresearch.com) is an international market research and consulting firm, dedicated to providing the best in business intelligence for the medical device industry. Our research empowers our clients by providing them with the necessary tools to achieve their goals and do it right the first time. iData covers research in: Dental Operatory Equipment, Dental Material, Dental Lasers, Dental Prosthetics, Dental CAD/CAM, Dental Bone Graft Substitutes, Ultrasound, X-Ray Imaging, Diagnostic Imaging, Oncology, Ophthalmics, Vascular Access, Laparoscopy, Urology, Gynecology, Endoscopy, Interventional Cardiology, Cardiac Surgery, Cardiac Rhythm Management, Electrophysiology, Operating Room Equipment, Surgical Microscopes, Robotics and Surgical Navigation, Spinal Implants and VCF, Spinal MIS, Orthopedic Soft Tissue Repair and Regeneration, Orthopedic Trauma, Large & Small Joints, Anesthesiology, Wound Management, Orthopedics and more. We have built a reputation and earned our clients' trust based on consistent and uniquely intelligent research that allows our customers to make confident decisions and impact their businesses. A combination of market expertise and over a decade of experience has resulted in a deep understanding of the medical device industry that has inspired innovation and propelled our clients to success. To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/nobel-biocare-straumann-dentsply-sirona-lead-us-dental-implant-fixtures-market-despite-pricing-pressure-from-low-cost-competitors-300464649.html

Loading MIS collaborators
Loading MIS collaborators